CClinicalTrials.gg
Status unknownNCT05045911Updated Sep 16, 2021

An Endoscopic Barbed-clips Suturing for Colorectal ESD

An interventional study of Endoscopic Barbed-clips Suturing in Colorectal Neoplasms, sponsored by Affiliated Hospital to Academy of Military Medical Sciences. Status unknown at 2 sites in China. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2021-09-16.

Sponsored by Affiliated Hospital to Academy of Military Medical Sciences · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
20 Years and older
Sex
All
01

Study summary

Endoscopic submucosal dissection (ESD) was developed to allow en bloc resection of colorectal neoplasm. Although colorectal ESD has been widely accepted as a minimally invasive treatment option for early colorectal neoplasm, post-ESD bleeding is one of the major adverse events. After ESD procedure, endoscopists close the defects with devices to prevent complications. A novel endoscopic barbed-clips suturing has been developed to simplify endoscopic closure. In this study, the endoscopic barbed-clips will be evaluated when closing defects in the colon after ESD.

Read the detailed description

Endoscopic submucosal dissection (ESD) has emerged as a new endoscopic technique that allows en-bloc resection of GI lesions, irrespective of size. The most common complications of the ESD techniques are bleeding and perforation. Several reports have shown that if prophylactic closure of a mucosal defect with clips would reduce the risk of bleeding following endoscopic intervention by ESD. With the advancements in endoscopic therapy, various techniques for prevention of post-ESD complications have been reported. However, there have some limitations including their inability to close large defects and the complexity of the approaches and the need for expensive equipment to complete the procedure. To address these issues, we have devised a novel endoscopic barbed-clips suturing method for mucosal defect closure after endoscopic submucosal dissection of colon. In this study, we assessed the technical feasibility of this novel technique.

02

Conditions studied

  • Colorectal Neoplasms
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's planned enrollment of 35 is below the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Affiliated Hospital to Academy of Military Medical Sciences is the lead sponsor of 65 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • aged≥20 years with a single clinically or histologically diagnosed colorectal lesions of 20-50mm eligible for which fulfilled criteria for ESD;

Exclusion criteria

Exclusion Criteria:

  • Patients with coagulopathy (platelet count \< 5 × 10*4, prothrombin time international normalized ratio > 2,
  • medical conditions requiring the continuous use of antithrombotic agents
  • prior abdominal surgery or radiation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    Endoscopic Barbed-clips Suturing

    Patients will be closed the mucosal defect after colorectal ESD using Endoscopic Barbed-clips Suturing.

    Procedure: Endoscopic Barbed-clips Suturing

Interventions

  • ProcedureEndoscopic Barbed-clips Suturing

    Endoscopic Barbed-clips Suturing

06

What researchers measure

Primary outcomes

  1. The technical success rate

    Rate of completely closure of the ESD defect

    Time frame: 1 day

Secondary outcomes

  1. Endoscopic barbed-clips suturing closure time

    The time required to close the defect using endoscopic barbed-clips suturing

    Time frame: 1 day

  2. Rate of patients reported with bleeding/perforation post-ESD procedure

    Conduct follow-ups for risk of bleeding and perforation after closure

    Time frame: 7 days

  3. Clips used post-ESD

    Record number of clips needed to close lesion

    Time frame: 7 days

07

Study locations

2 of 2 sites recruiting
  • The Fifth Medical Center of Chinese PLA General Hospital
    Beijing, Beijing 100071, China
    • Min Min, Dr. · Contact · minmin823@sina.com · +8613426165452
    • Yan Liu, Pro. · Principal investigator
    Recruiting
  • The First Medical Center of Chinese PLA General Hospital
    Beijing, Beijing 100853, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05045911
Lead sponsor
Affiliated Hospital to Academy of Military Medical Sciences
Responsible party
Sponsor
First posted
Sep 16, 2021
Start date
Sep 20, 2021 (estimated)
Primary completion
Dec 1, 2021 (estimated)
Completion
Dec 20, 2021 (estimated)
Last update
Sep 16, 2021

Study contacts

Yiliang Bi, Dr.
Contact
yiliangbi@163.com
+8613240439961
Pei Deng, Dr.
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion